A research team from IRB Barcelona and the biotech Nostrum Biodiscovery has developed a new type of inhibitor that blocks only some of the functions of the p38 protein. The alternative pathway that ...
Shanghai Meiyue Biotech Development Co. Ltd. has discovered MAPK p38 inhibitors reported to be useful for the treatment of arthritis, psoriasis, systemic lupus erythematosus, diabetes, cancer, ...
Co announces new Phase 1 clinical data on its M.E.K inhibitor, ARRY-162, and its p38 inhibitor, ARRY-797. Array presented preliminary information on its M.E.K inhibitor, ARRY-162, from both a single ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results